Tag: FDA IND submission

CTD and eCTD Submissions: Structure and Best Practices

Posted on digi By digi

CTD and eCTD Submissions: Structure and Best Practices Best Practices for CTD and eCTD Submissions in Clinical Trials Introduction: The Role of CTD and eCTD in Regulatory Submissions The Common Technical Document (CTD) and its electronic counterpart, eCTD, are the standardized formats for submitting clinical trial and marketing authorization applications globally. For US sponsors, the…

Read More “CTD and eCTD Submissions: Structure and Best Practices” »

Clinical Trial Operations & Compliance, Regulatory Submissions (CTD/eCTD)

Essential Elements of a Successful IND Package

Posted on digi By digi

Essential Elements of a Successful IND Package What Makes an IND Submission Package Complete and Compliant? Introduction to the IND Package An Investigational New Drug (IND) application is a regulatory prerequisite for initiating clinical trials in the United States. It allows sponsors to legally ship an investigational drug across state lines before a marketing application…

Read More “Essential Elements of a Successful IND Package” »

IND (Investigational New Drug) Submissions, Regulatory Submissions and Approvals

Regulatory Submissions and IRB Coordination in Clinical Trials

Posted on digi By digi

Effective Coordination of Regulatory Submissions and IRB Approvals One of the most critical components of clinical study start-up is the preparation and coordination of regulatory submissions and Institutional Review Board (IRB) approvals. A smooth regulatory process ensures ethical compliance, protects subjects, and prevents study delays. This tutorial outlines best practices, timelines, and responsibilities in regulatory…

Read More “Regulatory Submissions and IRB Coordination in Clinical Trials” »

Clinical Research Operations, Study Start-Up Activities